Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1

Status

Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 13Breast 3Gynecologic 2Gastrointestinal 2Other hematologic neoplasm 1Lymphoid 1

Conditions

Ovarian Neoplasms 142Endometrial Neoplasms 85Uterine Cervical Neoplasms 71Breast Neoplasms 42Fallopian Tube Neoplasms 38Colorectal Neoplasms 34Carcinoma, Non-Small-Cell Lung 32Pancreatic Neoplasms 24Neoplasms 23Prostatic Neoplasms 22Neoplasm Metastasis 21Stomach Neoplasms 19Triple Negative Breast Neoplasms 18Urinary Bladder Neoplasms 17Esophageal Neoplasms 17Melanoma 16Squamous Cell Carcinoma of Head and Neck 15Lung Neoplasms 15Carcinoma, Renal Cell 15Carcinoma, Ovarian Epithelial 15Head and Neck Neoplasms 14Sarcoma 13Carcinoma, Hepatocellular 13Uterine Neoplasms 11Colonic Neoplasms 11Cholangiocarcinoma 11Carcinoma, Transitional Cell 11Rectal Neoplasms 10Vulvar Neoplasms 9Small Cell Lung Carcinoma 9

Interventions

Tirzepatide 1Tablets 1Megestrol Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Obesity × Gynecologic × 30 days × Clear all
NCT05316467 2026-06-04

Weight Management Plus Megestrol Acetate in Early-stage Endometrioid Carcinoma

Fudan University

Phase 2/3 Terminated
8 enrolled
GynecologicOther

Infertility, Obesity, Endometrial Neoplasms, Overweight

NCT07078838 2026-06-04

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting
40 enrolled
GynecologicOther

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡